Results 131 to 140 of about 1,774 (156)

A multi-isolate genomic approach identifies diverse <i>Escherichia coli</i> contamination and antimicrobial resistance carriage on retail foods. [PDF]

Microb Genom
Astorga G, Bloomfield SJ, Palau R, Janecko N, de Oliveira Martins L, Singh D, Zamudio R, Savva GM, Wain J, Mather AE.   +9 more
europepmc   +1 more source

Epidemiological features of scrub typhus and molecular characteristics of Orientia tsutsugamushi in north-central Bangladesh. [PDF]

IJID Reg
Nila SS, Aung MS, Haque N, Paul SK, Nasreen SA, Roy S, Ahmed S, Khanam J, Sayeed MAAB, Paul S, Urushibara N, Kawaguchiya M, Ohashi N, Kobayashi N.   +13 more
europepmc   +1 more source

Post-pandemic upsurge in Group A Streptococcus infections at an Italian tertiary university hospital. [PDF]

Microbiol Spectr
Arcari G, Novazzi F, Colombini L, Drago Ferrante F, Boutahar S, Paolo Genoni A, Cassani G, Gigante P, Carbotti M, Bianco A, Tirziu M, Capuano R, Pasciuta R, Iannelli F, Clementi N, Santoro F, Mancini N.   +16 more
europepmc   +1 more source

Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β

Molecular Cancer Therapeutics, 2022
Abstract CCAAT/enhancer binding protein β (C/EBPβ) is a basic leucine zipper (bZIP) family transcription factor, which is upregulated or overactivated in many cancers, resulting in a gene expression profile that drives oncogenesis.
Emad Darvishi, Lila Ghamsari, Siok Leong   +2 more
exaly   +3 more sources

Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital [PDF]

Journal of Antimicrobial Chemotherapy, 2013
Sir, Clonally diverse NDM-1-producing Escherichia coli (ST405, ST131, ST156 and ST101) have been reported globally, including on the Indian subcontinent. Indeed, there may be an association between isolates of NDM-1-producing E. coli ST101, phylogroup B1, that have been identified in Australia, Canada, Germany, the UK and Pakistan.
Ji Woo Yang, Yeong Seon Lee, Jung Sik Yoo   +2 more
exaly   +3 more sources

ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo [PDF]

Annals of Neurology, 2011
AbstractObjective:Inhibiting Aβ generation is a prime therapeutic goal for preventing or treating Alzheimer disease. Here we sought to identify any disease‐modifying properties of an azaindolizinone derivative, spiro[imidazo[1,2‐a]pyridine‐3,2‐idan]‐2(3H)‐one (ST101 or ZSET1446).Methods:The effects of ST101 were studied in 3xTg‐AD mice and young ...
Kim N Green, Frank M Laferla
exaly   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Abstract 959: C/EBPβ antagonist peptide, ST101, as a therapeutic approach in breast cancer

Cancer Research, 2021
Abstract Breast cancer (BC) is the most common invasive cancer in women, with more than 2.1 million cases and over 626,000 deaths occurring worldwide annually. Although age-adjusted mortality from BC has been declining since 1990, the median survival for patients with metastatic disease remains at 2-3 years, and 5-year survival ...
Jim A. Rotolo, Mark Koester, Ricardo Ramirez, Lila Ghamsari, Siok Leong, Erin Gallagher, Gene Merutka, Barry J. Kappel   +7 more
  +4 more sources

KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India

Journal of Medical Microbiology, 2018
This study characterizes KPC-2 producing Klebsiella pneumoniae belonging to ST101. Whole genome sequencing using the Ion Torrent PGM platform with 400 bp chemistry was performed. blaKPC-2 was found on an IncFIIK plasmid associated with ISKpn6 and ISKpn7 without Tn4401. This is the first report of KPC-2 K. pneumoniae from bacteremia in India.
Chaitra Shankar, Abi Manesh, Balaji Veeraraghavan   +2 more
exaly   +3 more sources